← SynDRA
AR-A014418
SynDRA canonical compound SYN1957299 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | GSK3B |
| Mechanism of action | glycogen synthase kinase inhibitor |
All known targets
Mechanisms of action (all sources)
- glycogen synthase kinase inhibitor
Cross-references
Synonyms
- GSK-3beta Inhibitor VIII
- 1-(4-methoxybenzyl)-3-(5-nitrothiazol-2-yl)urea
- 1-[(4-methoxyphenyl)methyl]-3-(5-nitro-1,3-thiazol-2-yl)urea
- A Inhibitor VIII
- N-(4-METHOXYBENZYL)-N'-(5-NITRO-1,3-THIAZOL-2-YL)UREA
- UNII-87KSH90Q6D
- AR-AO 14418
- SN 4521
- AR-A 014418
- CHEMBL259850
- 87KSH90Q6D
- N-[(4-Methoxyphenyl)methyl]-N'-(5-nitro-2-thiazolyl)urea
- AK175829
- C12H12N4O4S
- N-(4-Methoxybenzyl)-N&
- -(5-nitro-1,3-thiazol-2-yl)urea
- AR 014418
- GSK 3be
Look up AR-A014418 in the interactive SynDRA portal →